Abstract

Increasing evidence has shown the mechanistic insights about non-coding RNA 7SK in controlling the transcription. However, the biological function and mechanism of 7SK in cancer are largely unclear. Here, we show that 7SK is down-regulated in human tongue squamous carcinoma (TSCC) and acts as a TSCC suppressor through multiple cell-based assays including a migration assay and a xenograft mouse model. The expression level of 7SK was negatively correlated with the size of tumors in the 73 in-house collected TSCC patients. Through combined analysis of 7SK knockdown of RNA-Seq and available published 7SK ChIRP-seq data, we identified 27 of 7SK-regulated genes that were involved in tumor regulation and whose upstream regulatory regions were bound by 7SK. Motif analysis showed that the regulatory sequences of these genes were enriched for transcription factors FOXJ3 and THRA, suggesting a potential involvement of FOXJ3 and THRA in 7SK-regulated genes. Interestingly, the augmented level of FOXJ3 in TSCC patients and previous reports on THRA in other cancers have suggested that these two factors may promote TSCC progression. In support of this idea, we found that 21 out of 27 aforementioned 7SK-associated genes were regulated by FOXJ3 and THRA, and 12 of them were oppositely regulated by 7SK and FOXJ3/THRA. We also found that FOXJ3 and THRA dramatically promoted migration in SCC15 cells. Collectively, we identified 7SK as an antitumor factor and suggested a potential involvement of FOXJ3 and THRA in 7SK-mediated TSCC progression.

Highlights

  • Despite its well-investigated molecular mechanism in snRNP activity control, the biological function of 7SK is largely unclear

  • Our results showed that the expression level of 7SK in 46 out of 73 tongue squamous carcinoma (TSCC) samples (63%) were significantly decreased when compared to the matched non-malignant counterpart (Tumor/Non-malignant, T/N) (Figures 1A,B)

  • Note that there is no significant difference between 7SK expression and clinicopathological factors such as age, gender, or lymph nodes metastatic (Supplementary Table 1) or prognosis of TSCC patients (Supplementary Figure 1)

Read more

Summary

Introduction

Despite its well-investigated molecular mechanism in snRNP activity control, the biological function of 7SK is largely unclear. It has been shown that the expression level of 7SK was down-regulated in breast cancer, colon cancer, and Chronic Myelogenous Leukemia (CML) (Abasi et al, 2016). These reports suggested that 7SK may possess a tumor-suppressive role. In view of the critical role of 7SK as a general regulator in gene transcription control and the suggestive dysregulation of 7SK in the previously reported cancer types, it would be of great interest to explore the biological function of 7SK in cancer and the underlying regulatory mechanism

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call